The Novavax COVID-19 vaccine is made with an old school technology, but will it be enough to win over vaccine skeptics?
LOS ANGELES -- An FDA advisory panel is set to review the data on a potential fourth coronavirus vaccine on Tuesday.Novavax is the underdog in the COVID-19 vaccine race where many Southern Californians are already on their third or fourth shot.
Kim says that Novavax is made by taking the protein of an infectious agent and mixing it with a substance which enhances the body's immune response. With Novavax, Kim said the data shows five myocarditis cases out of 30,000 compared to just one in the placebo group.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Advisers Consider Novavax COVID-19 Vaccine This WeekThe FDA’s vaccine advisors are scheduled to meet on Tuesday to consider authorizing the Novavax COVID-19 vaccine. The committee will vote on whether the benefits of the two-dose vaccine outweigh the risks for ages 18 and older.
Read more »
COVID-19 cases up 30 percent within the last week in Southern CaliforniaAs large crowds gather at events, beaches and airports, COVID-19 cases are climbing in Southern California.
Read more »
Missions cancel weekend games after positive COVID-19 testsSaturday’s game against Tulsa was called off about an hour before the scheduled first...
Read more »
Orange County man to plead guilty to $5-million COVID-19 relief loan scamRaghavender Reddy Budamala reportedly used the loans to purchase a $1.2 million 'investment property' in Eagle Rock, a nearly $600,000 property in Malibu and a 'personal residence' in Irvine.
Read more »
We Can't Keep Getting The Same Formula in COVID-19 Booster Shots, Says ImmunologistBeing up to date on COVID-19 vaccines means having had three or four doses of the same shot at this point. Current boosters are the same formulations as the first authorized shots, based on the original strain of the coronavirus that emerged in late
Read more »
Why Variants Keep Covid-19 Cases Simmering in the U.S.A look at some of the Covid-19 data underlying Omicron’s recent spread suggests that an increasing share of Americans have some immunity against SARS-Cov-2, but the virus’s latest subvariant can sidestep our defenses.
Read more »